Trevia

Therapeutic Segment:

Anti-Diabetic

Generic Name:

Sitagliptin phosphate monohydrate

Indication

  • 50MG
  • 100MG

As an adjunct to diet & exercise in adult patients with Type 2 Diabetes Mellitus to improve glycemic control. As dual oral therapy in adult patients with metformin or sulfonylurea in insufficient glycemic control.